loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 864f1c02 761f 4049 89fa 7aeec4118226 Applno 205580 Form Solution Intravenous Dosage 100mg 4ml 25mg Ml - Drug Product Composition: Treanda

    Menu

    Treanda

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 32,714Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 205580 / DOSAGE - SOLUTION;INTRAVENOUS - 100MG/4ML (25MG/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BENDAMUSTINE HYDROCHLORIDE(UNII: 981Y8SX18M)
    (BENDAMUSTINE - UNII:9266D9P3PQ)     		BENDAMUSTINE HYDROCHLORIDE100mg

    Inactive Ingredients

    Ingredient Name
    Apotex Corp
    Eagle Pharmaceuticals, Inc
    Teva Pharmaceuticals USA, Inc.
    ALCOHOL(3K9958V90M)  
    MONOTHIOGLYCEROL(AAO1P0WSXJ)
    POLYETHYLENE GLYCOL 400(B697894SGQ) 
    POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)  
    PROPYLENE GLYCOL(6DC9Q167V3) 
    SODIUM HYDROXIDE (55X04QC32I)  
    SODIUM HYDROXIDE(55X04QC32I)